Get started
Author

Michael Mina

Observed names: M. M. Mina, Michael M Mina, Michael M. Mina, Michael Mokhlis Mina
ORCID: 0000-0001-8644-5702
Observed ORCID: 0000-0001-8644-5702
OpenAlex ID: A5080762319
HIV and co‐infections
2013 · Christina C. Chang, Megan Crane, et al. · Immunological Reviews · 186
Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection
2021 · Arunasingam Abayasingam, Harikrishnan Balachandran, et al. · Cell Reports Medicine · 73
PDF
Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses
2022 · Harikrishnan Balachandran, Chansavath Phetsouphanh, et al. · Cell Reports · 49
PDF
Envelope-Specific IgG3 and IgG1 Responses Are Associated with Clearance of Acute Hepatitis C Virus Infection
2020 · Melanie R. Walker, Auda A. Eltahla, et al. · Viruses · 28
PDF
Resistance to hepatitis C virus: potential genetic and immunological determinants
2015 · Michael M Mina, Fabio Luciani, et al. · The Lancet Infectious Diseases · 27
PDF
Protection against hepatitis C infection via NK cells in highly-exposed uninfected injecting drug users
2014 · Peter B. Sugden, Barbara Cameron, et al. · Journal of Hepatology · 26
Hepatitis C in Australian prisons: a national needs assessment
2016 · Michael Mokhlis Mina, Lilie Herawati, et al. · International Journal of Prisoner Health · 14
Enhancing hepatitis C treatment in the custodial setting: a national roadmap
2014 · Michael M Mina, Paul J Clark, et al. · The Medical Journal of Australia · 13
High activation levels maintained in receptor‐binding domain–specific memory B cells in people with severe coronavirus disease 2019
2022 · Money Gupta, Harikrishnan Balachandran, et al. · Immunology and Cell Biology · 7
PDF
Longitudinal Characterization of Phagocytic and Neutralization Functions of Anti-Spike Antibodies in Plasma of Patients after Severe Acute Respiratory Syndrome Coronavirus 2 Infection
2022 · Anurag Adhikari, Arunasingam Abayasingam, et al. · The Journal of Immunology · 5
PDF
Comparative Longitudinal Serological Study of Anti-SARS-CoV-2 Antibody Profiles in People with COVID-19
2023 · Marilou H. Barrios, Suellen Nicholson, et al. · Microorganisms · 4
PDF
Natural killer cells in highly exposed hepatitis C‐seronegative injecting drug users
2016 · M. M. Mina, B. Cameron, et al. · Journal of Viral Hepatitis · 4
Anti‐envelope antibody responses in highly exposed seronegative individuals may be associated with protection from HCV infection
2020 · Michael Mina, Alexander Underwood, et al. · Journal of Viral Hepatitis · 2
Long-Term Persistence of Neutralizing Memory B Cells in SARS-CoV-2
2020 · Arunasingam Abayasingam, Harikrishnan Balachandran, et al. · SSRN Electronic Journal · 1
Blood-Borne Viruses in New South Wales Prisons: Results from a Multi-Centre Study in Australia
2011 · Michael Mina · Journal of Infection · 1
C3d Complement Activation and Antibody Immunity in Convalescent COVID‐19: Insights From Adults and Children
2026 · Ratna Wijaya, Jordan Stoddart, et al. · Journal of Immunology Research
Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia
2023 · Nila J. Dharan, Sarah C. Sasson, et al. · PLoS ONE
PDF
Works count: 17
Citation count: 440
H-index: 8
I10-index: 8
Year
Topic
Type